Form 8-K - Current report:
SEC Accession No. 0001104659-25-057640
Filing Date
2025-06-09
Accepted
2025-06-09 09:01:27
Documents
23
Period of Report
2025-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517474d1_8k.htm   iXBRL 8-K 62117
2 EXHIBIT 3.1 tm2517474d1_ex3-1.htm EX-3.1 291747
3 EXHIBIT 3.2 tm2517474d1_ex3-2.htm EX-3.2 12364
4 EXHIBIT 4.1 tm2517474d1_ex4-1.htm EX-4.1 169223
5 EXHIBIT 4.2 tm2517474d1_ex4-2.htm EX-4.2 92647
6 EXHIBIT 10.1 tm2517474d1_ex10-1.htm EX-10.1 280517
7 EXHIBIT 10.2 tm2517474d1_ex10-2.htm EX-10.2 158003
8 EXHIBIT 10.3 tm2517474d1_ex10-3.htm EX-10.3 73233
9 EXHIBIT 10.4 tm2517474d1_ex10-4.htm EX-10.4 21474
10 EXHIBIT 10.5 tm2517474d1_ex10-5.htm EX-10.5 51959
11 EXHIBIT 10.6 tm2517474d1_ex10-6.htm EX-10.6 59270
12 EXHIBIT 99.1 tm2517474d1_ex99-1.htm EX-99.1 11323
  Complete submission text file 0001104659-25-057640.txt   1783738

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA snpx-20250604.xsd EX-101.SCH 3020
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20250604_lab.xml EX-101.LAB 34239
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20250604_pre.xml EX-101.PRE 22362
25 EXTRACTED XBRL INSTANCE DOCUMENT tm2517474d1_8k_htm.xml XML 3802
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 251032942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)